Receptor activado por proliferador de peroxisomas (Spanish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Receptor activado por proliferador de peroxisomas" in Spanish language version.

refsWebsite

Global rank Spanish rank

20doi.org

2^nd place

19nih.gov

4^th place

3harvard.edu

18^th place

34^th place

2semanticscholar.org

11^th place

79^th place

1issn.org

57^th place

3^rd place

1sciencedirect.com

149^th place

128^th place

1openmedicinalchemistryjournal.com

low place

doi.org

dx.doi.org

Michalik L. , Auwerx J. , Berger J.P. , Chatterjee V.K., Glass C.K., Gonzalez F.J., Grimaldi P.A., Kadowaki T., Lazar M.A., O'Rahilly S., Palmer C.N., Plutzky J., Reddy J.K., Spiegelman B.M., Staels B., Wahli W. (2006). «International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors». Pharmacol. Rev. 58 (4): 726-741. PMID 17132851. doi:10.1124/pr.58.4.5.
Dunning, Kylie R.; Anastasi, Marie R.; Zhang, Voueleng J.; Russell, Darryl L.; Robker, Rebecca L. (5 de febrero de 2014). «Regulation of Fatty Acid Oxidation in Mouse Cumulus-Oocyte Complexes during Maturation and Modulation by PPAR Agonists». PLOS ONE 9 (2): e87327. Bibcode:2014PLoSO...987327D. ISSN 1932-6203. PMC 3914821. PMID 24505284. doi:10.1371/journal.pone.0087327.
Belfiore A. , Genua M. , Malaguarnera R. (2009). «PPAR-gamma Agonists and Their Effects on IGF-I Receptor Signaling: Implications for Cancer». PPAR Res 2009: 830501. PMC 2709717. PMID 19609453. doi:10.1155/2009/830501.
Berger J., Moller D.E. (2002). «The mechanisms of action of PPARs». Annu. Rev. Med. 53: 409-435. PMID 11818483. doi:10.1146/annurev.med.53.082901.104018.
Feige JN. , Gelman L. , Michalik L. , Desvergne B. , Wahli W. (2006). «From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions». Prog. Lipid Res. 45 (2): 120-159. PMID 16476485. doi:10.1016/j.plipres.2005.12.002.
Tyagi S. , Gupta P. , Saini AS. , Kaushal C. , Sharma S. (October 2011). «The peroxisome proliferator-activated receptor: A family of nuclear receptors role in various diseases». J Adv Pharm Technol Res 2 (4): 236-40. PMC 3255347. PMID 22247890. doi:10.4103/2231-4040.90879.
Dreyer C. , Krey G. , Keller H. , Givel F. , Helftenbein G. , Wahli W. (1992). «Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors». Cell 68 (5): 879-87. PMID 1312391. doi:10.1016/0092-8674(92)90031-7.
Issemann I. , Green S. (1990). «Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators». Nature 347 (6294): 645-650. Bibcode:1990Natur.347..645I. PMID 2129546. doi:10.1038/347645a0.
Schmidt A, Endo N, Rutledge SJ, Vogel R, Shinar D, Rodan GA (1992). «Identification of a new member of the steroid hormone receptor superfamily that is activated by a peroxisome proliferator and fatty acids». Mol. Endocrinol. 6 (10): 1634-41. PMID 1333051. S2CID 23506853. doi:10.1210/mend.6.10.1333051.
Corton JC. , Peters JM. , Klaunig JE. (2018). «The PPARα-dependent rodent liver tumor response is not relevant to humans: addressing misconceptions». Journal of Molecular Endocrinology 92 (1): 83-119. PMC 6092738. PMID 29197930. doi:10.1007/s00204-017-2094-7.
«Peroxisome Proliferator-Activated Receptors». Reference Module in Life Sciences 17. Elsevier. 2021. pp. 574-583. ISBN 9780128096338. doi:10.1016/B978-0-12-819460-7.00200-0.
Yu S, Reddy JK. (2007). «Transcription coactivators for peroxisome proliferator-activated receptors». Biochim. Biophys. Acta 1771 (8): 936-951. PMID 17306620. doi:10.1016/j.bbalip.2007.01.008.
Ezzeddini R, Taghikhani M, Salek Farrokhi A, Somi MH, Samadi N, Esfahani A, Rasaee, MJ. (May 2021). «Downregulation of fatty acid oxidation by involvement of HIF-1α and PPARγ in human gastric adenocarcinoma and its related clinical significance». Journal of Physiology and Biochemistry 77 (2): 249-260. PMID 33730333. S2CID 232300877. doi:10.1007/s13105-021-00791-3.
Marlow LA, Reynolds LA, Cleland AS, Cooper SJ, Gumz ML, Kurakata S, Fujiwara K, Zhang Y, Sebo T, Grant C, McIver B, Wadsworth JT, Radisky DC, Smallridge RC, Copland JA. (February 2009). «Reactivation of suppressed RhoB is a critical step for the inhibition of anaplastic thyroid cancer growth». Cancer Res. 69 (4): 1536-44. PMC 2644344. PMID 19208833. doi:10.1158/0008-5472.CAN-08-3718.
Meirhaeghe A, Amouyel P. (2004). «Impact of genetic variation of PPARgamma in humans». Mol. Genet. Metab. 83 (1–2): 93-102. PMID 15464424. doi:10.1016/j.ymgme.2004.08.014.
Buzzetti R. , Petrone A. , Ribaudo M.C., Alemanno I., Zavarella S., Mein C.A., Maiani F., Tiberti C., Baroni M.G., Vecci E., Arca M., Leonetti F., Di Mario U. (2004). «The common PPAR-gamma2 Pro12Ala variant is associated with greater insulin sensitivity». European Journal of Human Genetics 12 (12): 1050-4. PMID 15367918. doi:10.1038/sj.ejhg.5201283.
Zoete V, Grosdidier A, Michielin O (2007). «Peroxisome proliferator-activated receptor structures: ligand specificity, molecular switch and interactions with regulators». Biochim. Biophys. Acta 1771 (8): 915-25. PMID 17317294. doi:10.1016/j.bbalip.2007.01.007.
Atanasov AG, Wang JN, Gu SP, Bu J, Kramer MP, Baumgartner L, Fakhrudin N, Ladurner A, Malainer C, Vuorinen A, Noha SM, Schwaiger S, Rollinger JM, Schuster D, Stuppner H, Dirsch VM, Heiss EH. (2013). «Honokiol: a non-adipogenic PPARγ agonist from nature». Biochim. Biophys. Acta 1830 (10): 4813-9. PMC 3790966. PMID 23811337. doi:10.1016/j.bbagen.2013.06.021.
Atanasov AG, Blunder M, Fakhrudin N, Liu X, Noha SM, Malainer C, Kramer MP, Cocic A, Kunert O, Schinkovitz A, Heiss EH, Schuster D, Dirsch VM, Bauer R. (2013). «Polyacetylenes from Notopterygium incisum--new selective partial agonists of peroxisome proliferator-activated receptor-gamma». PLOS ONE (Public Library of Science) 8 (4): e61755. Bibcode:2013PLoSO...861755A. PMC 3632601. PMID 23630612. doi:10.1371/journal.pone.0061755.
Ammazzalorso, Alessandra; Amoroso, Rosa (28 de febrero de 2019). «Inhibition of PPARγ by Natural Compounds as a Promising Strategy in Obesity and Diabetes». The Open Medicinal Chemistry Journal (en inglés) 13 (1): 7-15. doi:10.2174/1874104501913010007.

harvard.edu

adsabs.harvard.edu

Dunning, Kylie R.; Anastasi, Marie R.; Zhang, Voueleng J.; Russell, Darryl L.; Robker, Rebecca L. (5 de febrero de 2014). «Regulation of Fatty Acid Oxidation in Mouse Cumulus-Oocyte Complexes during Maturation and Modulation by PPAR Agonists». PLOS ONE 9 (2): e87327. Bibcode:2014PLoSO...987327D. ISSN 1932-6203. PMC 3914821. PMID 24505284. doi:10.1371/journal.pone.0087327.
Issemann I. , Green S. (1990). «Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators». Nature 347 (6294): 645-650. Bibcode:1990Natur.347..645I. PMID 2129546. doi:10.1038/347645a0.
Atanasov AG, Blunder M, Fakhrudin N, Liu X, Noha SM, Malainer C, Kramer MP, Cocic A, Kunert O, Schinkovitz A, Heiss EH, Schuster D, Dirsch VM, Bauer R. (2013). «Polyacetylenes from Notopterygium incisum--new selective partial agonists of peroxisome proliferator-activated receptor-gamma». PLOS ONE (Public Library of Science) 8 (4): e61755. Bibcode:2013PLoSO...861755A. PMC 3632601. PMID 23630612. doi:10.1371/journal.pone.0061755.

issn.org

portal.issn.org

Dunning, Kylie R.; Anastasi, Marie R.; Zhang, Voueleng J.; Russell, Darryl L.; Robker, Rebecca L. (5 de febrero de 2014). «Regulation of Fatty Acid Oxidation in Mouse Cumulus-Oocyte Complexes during Maturation and Modulation by PPAR Agonists». PLOS ONE 9 (2): e87327. Bibcode:2014PLoSO...987327D. ISSN 1932-6203. PMC 3914821. PMID 24505284. doi:10.1371/journal.pone.0087327.

nih.gov

ncbi.nlm.nih.gov

Michalik L. , Auwerx J. , Berger J.P. , Chatterjee V.K., Glass C.K., Gonzalez F.J., Grimaldi P.A., Kadowaki T., Lazar M.A., O'Rahilly S., Palmer C.N., Plutzky J., Reddy J.K., Spiegelman B.M., Staels B., Wahli W. (2006). «International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors». Pharmacol. Rev. 58 (4): 726-741. PMID 17132851. doi:10.1124/pr.58.4.5.
Dunning, Kylie R.; Anastasi, Marie R.; Zhang, Voueleng J.; Russell, Darryl L.; Robker, Rebecca L. (5 de febrero de 2014). «Regulation of Fatty Acid Oxidation in Mouse Cumulus-Oocyte Complexes during Maturation and Modulation by PPAR Agonists». PLOS ONE 9 (2): e87327. Bibcode:2014PLoSO...987327D. ISSN 1932-6203. PMC 3914821. PMID 24505284. doi:10.1371/journal.pone.0087327.
Belfiore A. , Genua M. , Malaguarnera R. (2009). «PPAR-gamma Agonists and Their Effects on IGF-I Receptor Signaling: Implications for Cancer». PPAR Res 2009: 830501. PMC 2709717. PMID 19609453. doi:10.1155/2009/830501.
Berger J., Moller D.E. (2002). «The mechanisms of action of PPARs». Annu. Rev. Med. 53: 409-435. PMID 11818483. doi:10.1146/annurev.med.53.082901.104018.
Feige JN. , Gelman L. , Michalik L. , Desvergne B. , Wahli W. (2006). «From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions». Prog. Lipid Res. 45 (2): 120-159. PMID 16476485. doi:10.1016/j.plipres.2005.12.002.
Tyagi S. , Gupta P. , Saini AS. , Kaushal C. , Sharma S. (October 2011). «The peroxisome proliferator-activated receptor: A family of nuclear receptors role in various diseases». J Adv Pharm Technol Res 2 (4): 236-40. PMC 3255347. PMID 22247890. doi:10.4103/2231-4040.90879.
Dreyer C. , Krey G. , Keller H. , Givel F. , Helftenbein G. , Wahli W. (1992). «Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors». Cell 68 (5): 879-87. PMID 1312391. doi:10.1016/0092-8674(92)90031-7.
Issemann I. , Green S. (1990). «Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators». Nature 347 (6294): 645-650. Bibcode:1990Natur.347..645I. PMID 2129546. doi:10.1038/347645a0.
Schmidt A, Endo N, Rutledge SJ, Vogel R, Shinar D, Rodan GA (1992). «Identification of a new member of the steroid hormone receptor superfamily that is activated by a peroxisome proliferator and fatty acids». Mol. Endocrinol. 6 (10): 1634-41. PMID 1333051. S2CID 23506853. doi:10.1210/mend.6.10.1333051.
Corton JC. , Peters JM. , Klaunig JE. (2018). «The PPARα-dependent rodent liver tumor response is not relevant to humans: addressing misconceptions». Journal of Molecular Endocrinology 92 (1): 83-119. PMC 6092738. PMID 29197930. doi:10.1007/s00204-017-2094-7.
Yu S, Reddy JK. (2007). «Transcription coactivators for peroxisome proliferator-activated receptors». Biochim. Biophys. Acta 1771 (8): 936-951. PMID 17306620. doi:10.1016/j.bbalip.2007.01.008.
Ezzeddini R, Taghikhani M, Salek Farrokhi A, Somi MH, Samadi N, Esfahani A, Rasaee, MJ. (May 2021). «Downregulation of fatty acid oxidation by involvement of HIF-1α and PPARγ in human gastric adenocarcinoma and its related clinical significance». Journal of Physiology and Biochemistry 77 (2): 249-260. PMID 33730333. S2CID 232300877. doi:10.1007/s13105-021-00791-3.
Marlow LA, Reynolds LA, Cleland AS, Cooper SJ, Gumz ML, Kurakata S, Fujiwara K, Zhang Y, Sebo T, Grant C, McIver B, Wadsworth JT, Radisky DC, Smallridge RC, Copland JA. (February 2009). «Reactivation of suppressed RhoB is a critical step for the inhibition of anaplastic thyroid cancer growth». Cancer Res. 69 (4): 1536-44. PMC 2644344. PMID 19208833. doi:10.1158/0008-5472.CAN-08-3718.
Meirhaeghe A, Amouyel P. (2004). «Impact of genetic variation of PPARgamma in humans». Mol. Genet. Metab. 83 (1–2): 93-102. PMID 15464424. doi:10.1016/j.ymgme.2004.08.014.
Buzzetti R. , Petrone A. , Ribaudo M.C., Alemanno I., Zavarella S., Mein C.A., Maiani F., Tiberti C., Baroni M.G., Vecci E., Arca M., Leonetti F., Di Mario U. (2004). «The common PPAR-gamma2 Pro12Ala variant is associated with greater insulin sensitivity». European Journal of Human Genetics 12 (12): 1050-4. PMID 15367918. doi:10.1038/sj.ejhg.5201283.
Zoete V, Grosdidier A, Michielin O (2007). «Peroxisome proliferator-activated receptor structures: ligand specificity, molecular switch and interactions with regulators». Biochim. Biophys. Acta 1771 (8): 915-25. PMID 17317294. doi:10.1016/j.bbalip.2007.01.007.
Atanasov AG, Wang JN, Gu SP, Bu J, Kramer MP, Baumgartner L, Fakhrudin N, Ladurner A, Malainer C, Vuorinen A, Noha SM, Schwaiger S, Rollinger JM, Schuster D, Stuppner H, Dirsch VM, Heiss EH. (2013). «Honokiol: a non-adipogenic PPARγ agonist from nature». Biochim. Biophys. Acta 1830 (10): 4813-9. PMC 3790966. PMID 23811337. doi:10.1016/j.bbagen.2013.06.021.
Atanasov AG, Blunder M, Fakhrudin N, Liu X, Noha SM, Malainer C, Kramer MP, Cocic A, Kunert O, Schinkovitz A, Heiss EH, Schuster D, Dirsch VM, Bauer R. (2013). «Polyacetylenes from Notopterygium incisum--new selective partial agonists of peroxisome proliferator-activated receptor-gamma». PLOS ONE (Public Library of Science) 8 (4): e61755. Bibcode:2013PLoSO...861755A. PMC 3632601. PMID 23630612. doi:10.1371/journal.pone.0061755.

pubmed.ncbi.nlm.nih.gov

Ezzeddini R, Taghikhani M, Salek Farrokhi A, Somi MH, Samadi N, Esfahani A, Rasaee, MJ. (May 2021). «Downregulation of fatty acid oxidation by involvement of HIF-1α and PPARγ in human gastric adenocarcinoma and its related clinical significance». Journal of Physiology and Biochemistry 77 (2): 249-260. PMID 33730333. S2CID 232300877. doi:10.1007/s13105-021-00791-3.

openmedicinalchemistryjournal.com

Ammazzalorso, Alessandra; Amoroso, Rosa (28 de febrero de 2019). «Inhibition of PPARγ by Natural Compounds as a Promising Strategy in Obesity and Diabetes». The Open Medicinal Chemistry Journal (en inglés) 13 (1): 7-15. doi:10.2174/1874104501913010007.

sciencedirect.com

«Peroxisome Proliferator-Activated Receptors». Reference Module in Life Sciences 17. Elsevier. 2021. pp. 574-583. ISBN 9780128096338. doi:10.1016/B978-0-12-819460-7.00200-0.

semanticscholar.org

api.semanticscholar.org

Schmidt A, Endo N, Rutledge SJ, Vogel R, Shinar D, Rodan GA (1992). «Identification of a new member of the steroid hormone receptor superfamily that is activated by a peroxisome proliferator and fatty acids». Mol. Endocrinol. 6 (10): 1634-41. PMID 1333051. S2CID 23506853. doi:10.1210/mend.6.10.1333051.
Ezzeddini R, Taghikhani M, Salek Farrokhi A, Somi MH, Samadi N, Esfahani A, Rasaee, MJ. (May 2021). «Downregulation of fatty acid oxidation by involvement of HIF-1α and PPARγ in human gastric adenocarcinoma and its related clinical significance». Journal of Physiology and Biochemistry 77 (2): 249-260. PMID 33730333. S2CID 232300877. doi:10.1007/s13105-021-00791-3.